久久久久无码精品国产91福利-91精品国产情侣高潮对白-国产清纯白嫩初高生在线被c-97人妻精品一区二区三区-亚洲精品无码永久中文字幕-国产成本人片无码麻豆免费

Pipeline
Inhalation Spray (Soft Mist Inhaler, SMI)
Inhalation Spray (Soft Mist Inhaler, SMI)
A preparation that produces a solution, suspension, or emulsion for inhalation aerosols by means of a predetermined or quantitative atomizer.
Inhalation Aerosol (Metered Dose Inhaler, MDI)
Inhalation Aerosol (Metered Dose Inhaler, MDI)
It refers to the preparation of the raw material drug or the raw material drug and the additive and the suitable ejector jointly sealed in a pressure container with a quantitative valve system and a c
Dry Powder Inhaler (DPI)
Dry Powder Inhaler (DPI)
Solid raw drug alone or mixed with a suitable carrier, in the form of capsules, vesicles or multi-dose storage, using a special dry powder inhalation device, the patient inhales the atomized drug into
Nebulization
Nebulization
The liquid preparation for the nebulizer refers to the solution, suspension or emulsion produced continuously for inhalation aerosol through the nebulizer. The liquid preparation for inhalation includ
Nasal Sprays
Nasal Sprays
The route of administration is inhalation through the nasal cavity
Liposomes
Liposomes
A microvesicle that encloses a drug in a lipid bilayer
About us
  • Founded in 2007
  • Patents 30+
  • R&D personnel 100+
Learn more
News
Good News | CF PharmTech won the
Good News | CF PharmTech won the "Best Employer of Greater Suzhou" in 2022
On November 17, 2022, the 9th "Best Employers in Greater Suzhou" was officially announced by Suzhou Industrial Park Human Resources Development Co., LTD. With excellent human resource management pract
Nov.17.2022
Good news from CF PharmTech | The first domestic blockbuster product for the treatment of allergic rhinitis - Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (ShuFeiMin ?) was approved
Good news from CF PharmTech | The first domestic blockbuster product for the treatment of allergic rhinitis - Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray (ShuFeiMin ?) was approved
Today, CF PharmTech, Inc. (hereinafter referred to as: "CF PharmTech") independently developed the heavy product ShuFeiMin? (National drug approval number: H20223778, general
Nov.07.2022
Announcement of the receipt of the listing notice to <br > CF PharmTech, Inc.
Announcement of the receipt of the listing notice to
CF PharmTech, Inc.
Jul.25.2022
CF PharmTech has completed F round of 360 million yuan equity investment to support rapid development of domestic high-end inhalation products.
CF PharmTech has completed F round of 360 million yuan equity investment to support rapid development of domestic high-end inhalation products.
CF PharmTech, Inc. (CF PharmTech, Inc., referred to as "CF PharmTech"), following the completion of the E round of 630 million financing in January, once again completed the F round of 360 million yuan financing, a total of nearly 1 billion financing with
Jul.03.2020